Subscribe to Newsletter

Content by Maryam Mahdi:

Business & Regulation Business Practice

Time Will Always Tell

| Maryam Mahdi

Sitting Down With Dolores Schendel, Chief Executive Officer and Chief Scientific Officer at Medigene.

Business & Regulation COVID-19

Through the Fire

| Maryam Mahdi

How did pharma fare during 2021 and will the industry move forward as the pandemic continues to impact lives on a global scale?

Discovery & Development Drug Discovery

Join The Resistance

| Maryam Mahdi

Antimicrobial resistance is an ongoing challenge for the pharmaceutical industry. What solutions can be created to address the problem?

Discovery & Development Drug Discovery

Allergy Relief

| Maryam Mahdi

Allergies pose a significant challenge to patients worldwide. How can we use novel immunotherapy approaches to lessen their therapeutic burden?

Business & Regulation COVID-19

A View on the Future of R&D From the UK

| Maryam Mahdi

Pharma experts convened at the Pharmaceutical Industry Network Group’s annual conference to discuss the UK’s position in pharmaceutical innovation.

Discovery & Development Drug Discovery

A Step Closer to a Universal Flu Vaccine

| Maryam Mahdi

Can newly discovered antibodies help us do away with annual flu vaccinations?

Manufacture Packaging

Finding the New Barex

| Maryam Mahdi

How can we improve transdermal packaging options for the Indian pharmaceutical market?

Business & Regulation Business Practice

Let’s Shake Things Up

| Maryam Mahdi

Finding new ways to celebrate pharmaceutical achievements.

Discovery & Development Drug Discovery

The Next Frontier in HIV Prevention

| Maryam Mahdi

Exploring the potential of vaccines for treatment equity.

Business & Regulation Business Practice

With Great Power…

| Maryam Mahdi

Environmental, social, and governance (ESG) plans should be an integral part of any company that aims to thrive in today’s society.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register